XRF Scientific Limited (XRF.AX)
AUD 1.87
(0.54%)
AUD 1.87
(0.54%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 8.08 Million | 8.41 Million | 3.15 Million | 4.51 Million | 4.2 Million | 3.87 Million |
| Net Income | 8.88 Million | 7.68 Million | 6.08 Million | 5.13 Million | 3.12 Million | 2.13 Million |
| Depreciation & Amortization | 1.57 Million | 1.2 Million | 1.17 Million | 1.23 Million | 1.24 Million | 674.04 Thousand |
| Deferred income taxes | - | -5.57 Million | 108.88 Thousand | 71.72 Thousand | 97.83 Thousand | -55.74 Thousand |
| Stock-based compensation | - | 331.66 Thousand | 63.97 Thousand | - | - | - |
| Change in working capital | -3.21 Million | -1.6 Million | -4.08 Million | -1.91 Million | -408.98 Thousand | -1.03 Million |
| Other non-cash items | 4.93 Million | 6.37 Million | -191.9 Thousand | 4.07 Million | 5.31 Million | 1.06 Million |
| Investing Cash Flow | -1.64 Million | -782.43 Thousand | -1.11 Million | -652.62 Thousand | -753.4 Thousand | -641.5 Thousand |
| Investments in PPE | -1.64 Million | -782.43 Thousand | -519.49 Thousand | -652.62 Thousand | -753.4 Thousand | -521.1 Thousand |
| Acquisitions | - | - | -592.29 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -30.78 Thousand | -24.74 Thousand | -137.9 Thousand | -239.45 Thousand | -214.4 Thousand | -120.39 Thousand |
| Financing Cash Flow | -4.8 Million | -3.88 Million | -648.94 Thousand | -2.23 Million | -3.05 Million | -411.88 Thousand |
| Debt repayment | -452.73 Thousand | -696.18 Thousand | -1.94 Million | -111.19 Thousand | -1.32 Million | -748.47 Thousand |
| Dividends payments | -3.6 Million | -2.67 Million | -2.12 Million | -1.65 Million | -1.33 Million | -401.47 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -746.75 Thousand | -507.33 Thousand | 3.41 Million | -472.41 Thousand | -391.17 Thousand | 738.07 Thousand |
| Accounts receivables | -894.86 Thousand | -2.4 Million | -1.74 Million | -708.42 Thousand | 297.26 Thousand | 51.25 Thousand |
| Accounts payables | 92.34 Thousand | 928.29 Thousand | 1.04 Million | 320.78 Thousand | -380.35 Thousand | 585.43 Thousand |
| Inventory | -139.48 Thousand | -1.35 Million | -3 Million | -1.22 Million | -2.59 Million | -1.08 Million |
| Other working capital | -2.27 Million | 1.22 Million | -379.71 Thousand | -311.88 Thousand | 2.27 Million | -585.43 Thousand |
| Cash at beginning of period | 10.4 Million | 6.64 Million | 5.25 Million | 3.63 Million | 3.23 Million | 415.37 Thousand |
| Cash at end of period | 12.04 Million | 10.4 Million | 6.64 Million | 5.25 Million | 3.63 Million | 3.23 Million |
| Capital Expenditure | -1.64 Million | -782.43 Thousand | -519.49 Thousand | -652.62 Thousand | -753.4 Thousand | -521.1 Thousand |
| Effect of forex changes on cash | - | - | - | -1.00 | - | - |
| Net cash flow / Change in cash | 1.64 Million | 3.75 Million | 1.39 Million | 1.62 Million | 395.87 Thousand | 2.82 Million |
| Free Cash Flow | 6.44 Million | 7.63 Million | 2.63 Million | 3.85 Million | 3.44 Million | 3.35 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 8.88 Million | 4.4 Million | 4.48 Million | 7.68 Million | 3.94 Million | 3.73 Million |
| Depreciation & Amortization | 1.57 Million | 831.39 Thousand | 740.93 Thousand | 1.2 Million | 622.24 Thousand | 582.4 Thousand |
| Deferred income taxes | - | - | - | -5.57 Million | 2.31 Million | - |
| Stock-based compensation | - | - | 210.34 Thousand | 331.66 Thousand | 194.52 Thousand | 137.14 Thousand |
| Change in working capital | -3.21 Million | - | - | -1.6 Million | -3.17 Million | - |
| Other non-cash items | 4.93 Million | 2.34 Million | -1.57 Million | 6.37 Million | 2.79 Million | -862.79 Thousand |
| Investing Cash Flow | -1.64 Million | -508.19 Thousand | -1.13 Million | -782.43 Thousand | -489.58 Thousand | -292.84 Thousand |
| Investments in PPE | -1.64 Million | -508.19 Thousand | -1.13 Million | -782.43 Thousand | -489.58 Thousand | -292.84 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -6264.00 | -24.74 Thousand | -16.11 Thousand | -8634.00 |
| Financing Cash Flow | -4.8 Million | -1.68 Million | -3.11 Million | -3.88 Million | -1.29 Million | -2.58 Million |
| Debt repayment | -452.73 Thousand | -860.07 Thousand | -860.07 Thousand | -696.18 Thousand | - | -349.72 Thousand |
| Dividends payments | -3.6 Million | - | -3.6 Million | -2.67 Million | -50.00 | -2.67 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -746.75 Thousand | -825.36 Thousand | -374.11 Thousand | -507.33 Thousand | -1.29 Million | 90.33 Thousand |
| Accounts receivables | -894.86 Thousand | - | - | -2.4 Million | -2.4 Million | - |
| Accounts payables | 92.34 Thousand | - | - | 928.29 Thousand | - | - |
| Inventory | -139.48 Thousand | - | - | -1.35 Million | -1.35 Million | - |
| Other working capital | -2.27 Million | - | - | 1.22 Million | 579.39 Thousand | - |
| Cash at beginning of period | 10.4 Million | 8.32 Million | 10.4 Million | 6.64 Million | 6.06 Million | 6.64 Million |
| Cash at end of period | 12.04 Million | 12.04 Million | 8.32 Million | 10.4 Million | 10.4 Million | 6.06 Million |
| Capital Expenditure | -1.64 Million | -508.19 Thousand | -1.13 Million | -782.43 Thousand | -489.58 Thousand | -292.84 Thousand |
| Effect of forex changes on cash | - | - | -1.00 | - | -10.4 Million | 6.64 Million |
| Net cash flow / Change in cash | 1.64 Million | 3.72 Million | -2.07 Million | 3.75 Million | 4.34 Million | -588.25 Thousand |
| Free Cash Flow | 6.44 Million | 5.41 Million | 1.03 Million | 7.63 Million | 5.63 Million | 2 Million |
IES
6955
MMC
SBGLP
LPDC
2726